Newsroom
307 articles
FeaturedOn July 2, 2025, the FDA gave accelerated approval to linvoseltamab-gcpt (Lynozyfic, Regeneron Pharmaceuticals, Inc.), a targeted therapy that helps the immune system attack cancer cells. It is…
FeaturedThe Saudi food & drug authority has been actively working towards advancing public health in kingdom through ongoing strategic initiatives aimed at strengthening the healthcare system with the…
FeaturedBased on recent FDA findings the use of extended-release stimulants for ADHD management in children below 6 years old has been causing weight loss & other adverse events…
FeaturedAs of 1st of July 2025 regulations associated with the use of radioactive substances or ionizing radiation has changed to ease the process for applications in order to…
FeaturedPatients fighting extensive stage small cell lung cancer (SCLC) now have new hope with UK’s Medicines and Healthcare products Regulatory Agency (MHRA) recently approving serplulimab (Hetronifly) a PD-1…
FeaturedThe European Medicines Agency (EMA) has suggested granting provisional marketing authorization for Rezdiffra (resmetirom) the first treatment in the EU for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with modest…
FeaturedWith UK’s continuing efforts in providing better healthcare services & treatments for patients, comes the new initiative of providing at home cervical testing kits to screen for the…
FeaturedOn 24 June, the United Kingdom was the first country to join the HealthAI Global Regulatory Network, a new international initiative to ensure the safe and effective use…
FeaturedFinding a treatment for hematological malignancies can be a challenging as it mainly depends on finding a suitable donor & if they are lucky enough to find a…
FeaturedScopolamine transdermal patches were approved by the FDA in the 1970s for managing nausea and vomiting caused by motion sickness; later, they also got FDA approval for recovery…
FeaturedIn a significant advancement for lymphoma treatment, the FDA has approved Monjuvi (tafasitamab-cxix) in combination with lenalidomide and rituximab for adults with relapsed or refractory follicular lymphoma (FL).…
FeaturedWith continuous efforts to find new cancer treatments, comes to life a new ultrasound technology developed by a US based company called HistoSonics the device works by destroying…
FeaturedThe EMA has published a draft guideline for public consultation that offers recommendations on how to include and/or continue pregnant and breastfeeding individuals in clinical trials. The aim…
FeaturedNon-arteritic anterior ischemic optic neuropathy, or NAION, is a very rare eye condition that causes vision loss; it affects 1 in 10,000 patients taking Semaglutide for treatment of…
FeaturedWe now live in a time where innovation & technology are shaping our future from mobile phones to life saving inventions. The UK government has been investing in…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP